Healwell AI Inc. Stock

Equities

AIDX

CA42249X1006

Healthcare Facilities & Services

Market Closed - Toronto S.E. 04:00:00 2024-05-24 pm EDT 5-day change 1st Jan Change
1.72 CAD +3.61% Intraday chart for Healwell AI Inc. +4.24% +129.33%
Sales 2024 * 21.83M 16M Sales 2025 * 29.5M 21.61M Capitalization 223M 163M
Net income 2024 * -21M -15.39M Net income 2025 * -15M -10.99M EV / Sales 2024 * 10.2 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 7.55 x
P/E ratio 2024 *
-15.6 x
P/E ratio 2025 *
-19.1 x
Employees 102
Yield 2024 *
-
Yield 2025 *
-
Free-Float 38.06%
More Fundamentals * Assessed data
Dynamic Chart
Healwell AI Closes Upsized $20 Million Bought-Deal Private Placement of Share Units MT
Healwell AI Subsidiary Partners With Sunnybrook Hospital to Show AI Platform Role in Cancer Staging MT
Healwell AI Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Healwell AI First-Quarter Loss Narrows as Revenue Jumps MT
Transcript : Healwell AI Inc., Q1 2024 Earnings Call, May 14, 2024
HEALWELL AI Brief: Says Strategic alliance with WELL Health Technologies Corp. "Continues To Flourish" MT
HEALWELL AI Brief: Cites Potential to more than double yearly revenue run-rate to over $40 Million using the Co's existing cash on hand, not including proceeds of recently announced bought deal financing for Up to $20Mmillion MT
HEALWELL AI Brief: Management provides a "Positive Outlook" based on strong and active acquisition and business development pipeline MT
HEALWELL AI Brief: Says Achieved quarterly revenue from continuing operations of $4.58 million in Q1-2024, 132% higher compared to $1.97 million generated in Q1-2023 MT
Healwell AI to Raise $16 Million in Bought Deal Private Placement MT
Healwell AI Inc. announced that it expects to receive CAD 17.00001 million in funding CI
WELL Health Technologies Launches Upgraded Version of AI-Powered Physician Co-Pilot Tool MT
HEALWELL AI Unit Pentavere Publishes Paper Validating Use of Generative AI to Identify Rare Lung Cancer Patients MT
HEALWELL AI Brief: Says Its Pentavere Achieved Validation of Generative AI for Preventative Care Through Landmark Publication MT
HEALWELL AI's Q4 Loss Widens, Revenue Falls; Up 5.6% MT
More news
1 day+3.61%
1 week+4.24%
Current month+13.16%
1 month+11.69%
3 months+93.26%
6 months+82.98%
Current year+129.33%
More quotes
1 week
1.59
Extreme 1.585
1.81
1 month
1.39
Extreme 1.385
1.81
Current year
0.65
Extreme 0.65
1.93
1 year
0.12
Extreme 0.115
1.93
3 years
0.09
Extreme 0.085
3.30
5 years
0.09
Extreme 0.085
4.93
10 years
0.09
Extreme 0.085
4.93
More quotes
Managers TitleAgeSince
Founder - 20-08-31
Director of Finance/CFO - 20-08-31
Corporate Officer/Principal - 12-12-31
Members of the board TitleAgeSince
Chairman 49 23-09-30
Director/Board Member 66 20-12-28
Director/Board Member 60 20-12-28
More insiders
Date Price Change Volume
24-05-24 1.72 +3.61% 524,276
24-05-23 1.66 +0.61% 567,869
24-05-22 1.65 -1.79% 227,102
24-05-21 1.68 +1.82% 469,539

Delayed Quote Toronto S.E., May 24, 2024 at 04:00 pm EDT

More quotes
HEALWELL AI Inc. is a healthcare technology company focused on artificial intelligence (AI) and data science for preventative care. The Company is engaged in developing and acquiring technology and clinical sciences capabilities. Its clinical information sources consist of clinician and electronic medical records (EMR) access; clinical research and trials; lab and diagnostic info, and semi-structured data. It offers a range of clinical insights with life sciences companies, precision medicine companies, pharmaceutical companies, and medical device companies. It also focuses on identifying eligible patients for approved medications and interventions through its AI system, DARWEN. It offers Intrahealth an advanced software-as-a-service based HER management platform for small and medium enterprise healthcare organizations across Canada, Australia, and New Zealand. The platform meets the demands of a clients from a single doctor’s office to a multi-thousand user health institution.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.72 CAD
Average target price
1.9 CAD
Spread / Average Target
+10.47%
Consensus